Biomet, a manufacturer of musculoskeletal medical products, announced the initial closing of the previously announced acquisition of the worldwide trauma business of DePuy Orthopaedics.
As part of the initial closing, Biomet has acquired DePuy's trauma operations in the United States, the United Kingdom, Australia, New Zealand and Japan, as well as DePuy Trauma's manufacturing operations in Le Locle, Switzerland. Closings for the remaining countries will occur on a staggered basis within the next six months. DePuy Orthopaedics' affiliates will serve as Biomet's interim distributor in these countries until these country operations are fully transitioned to Biomet.
As part of the initial closing, Biomet has acquired DePuy's trauma operations in the United States, the United Kingdom, Australia, New Zealand and Japan, as well as DePuy Trauma's manufacturing operations in Le Locle, Switzerland. Closings for the remaining countries will occur on a staggered basis within the next six months. DePuy Orthopaedics' affiliates will serve as Biomet's interim distributor in these countries until these country operations are fully transitioned to Biomet.
Related Articles on Biomet:
FTC Approves Johnson & Johnson's $21.3B Acquisition of Synthes
20 Orthopedic Device Company Q1 Financial Report Updates
17 Spine Devices Receive FDA 510(k) Clearance in March